Mānuka: The hottest super-ingredient powering a skincare revolution
LOS ANGELES, Sept. 19, 2024 /PRNewswire/ — Get ready, Los Angeles! Launching soon, MN8 is shaking up skincare with a groundbreaking debut set to redefine natural beauty. The Mānuka Gold Extract—a powerful, world-first ingredient is taking skincare to the next level. Mānuka is known for it
NASA Sets Coverage for Astronaut Tracy C. Dyson, Crewmates Return
WASHINGTON, Sept. 19, 2024 /PRNewswire/ — NASA astronaut Tracy C. Dyson, accompanied by Roscosmos cosmonauts Nikolai Chub and Oleg Kononenko, will depart from the International Space Station aboard the Soyuz MS-25 spacecraft, and return to Earth. Dyson, Chub, and Kononenko will undock from th
RYBREVANT® (amivantamab-vmjw) plus standard of care approved in the U.S. as first and only targeted regimen to cut risk of disease progression by more than half in second-line EGFR-mutated advanced lung cancer
Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT® this year, with four indications overall RARITAN, N.J., Sept. 17, 2024 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Dr
Global claims guidance leader EvolutionIQ joins as CALI’s inaugural Life Partner
NEW YORK, Sept. 20, 2024 /PRNewswire/ — US-based EvolutionIQ, a global leader in claims guidance technology, has signed on as the Council of Australian Life Insurers (CALI)’s first Life Partner as part of its corporate partner program. The CALI Partner Program is designed to foster colla
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, FYBR, GATO, SGRP on Behalf of Shareholders
NEW YORK, Sept. 19, 2024 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Better Choice Company Inc. (NYSE: BTTR)’
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia’s lead drug narmafotinib in advanced pancreatic cancerFast Track Designation facilitates the development of investigational drugs and allows for expedited review MELBOURNE, Australia, Sept. 19, 2024 /PRNewswire/ — Amplia
Trinity Capital Inc. Increases its Credit Facility to $510 Million
PHOENIX, Sept. 19, 2024 /PRNewswire/ — Trinity Capital Inc. (Nasdaq: TRIN) (“Trinity” or the “Company”), a leading provider of diversified financial solutions to growth-stage companies, today announced an increase to $510 million of total commitments under its credit fa
Trinity Capital Inc. Increases its Credit Facility to $510 Million
PHOENIX, Sept. 19, 2024 /PRNewswire/ — Trinity Capital Inc. (Nasdaq: TRIN) (“Trinity” or the “Company”), a leading provider of diversified financial solutions to growth-stage companies, today announced an increase to $510 million of total commitments under its credit fa
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia’s lead drug narmafotinib in advanced pancreatic cancer Fast Track Designation facilitates the development of investigational drugs and allows for expedited review MELBOURNE, Australia, Sept. 19, 2024 /PRNewswire/ — Amplia
Mob Wives Creator and Bridgetown Street Productions Owner Jennifer Graziano Launches The UnOrganized Network in Partnership with Green Leaf Productions and Mark Spark Productions
NEW YORK, Sept. 19, 2024 /PRNewswire/ — Jennifer Graziano, creator of the hit TV series Mob Wives, is expanding by launching a podcast network with Emmy Award-winning producer Rudy Vegliante of Green Leaf Productions and Mark Spark Productions. ‘Mob Wives’ Creator and Bridgetown S
